Live FDA approvals issued by the Food and Drug Administration and FDA breaking news
Submission status for MYOKARDIA INC's drug CAMZYOS (ORIG-1) with active ingredient MAVACAMTEN has changed to 'Approval' on 04/28/2022. Application Category: NDA, Application Number: 214998, Application Classification: Type 1 - New Molecular Entity